Trial intelligence / Profile preview

Exparel for Rib Fracture Pain

NCT02390440Phase 4Withdrawn

Start
Apr 2015
Primary completion
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bupivacaine in pain. Planned start Apr 2015; status: withdrawn.

02

Drugs

bupivacaine
03

Conditions

pain

Beyond the preview

Go deeper on NCT02390440.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02390440.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call